Skip to main content
PMC home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;26(6):419–427. [Article in Spanish] doi: 10.1016/S0212-6567(00)78693-8

Prevención del cáncer de mama en atención primaria

JF Cameselle Teijeiro, ME Cortizo Torres, A López Touza, M Gómez Cuñarro, L Pousa Estévez, A Senra Varela *
PMCID: PMC7681466  PMID: 11111316

The content is available as a PDF (111.1 KB).

Bibliografía

  • 1.Morrow M., Jordan V.C. Tamoxifen for breast cancer prevention: ready for prime time? (Editorial) Breast J. 1998;4:407–408. [Google Scholar]
  • 2.Ibrahim N.K., Hortobagyi G.N. New antiestrogens in breast cancer: a review. Breast J. 1998;4:213–229. doi: 10.1046/j.1524-4741.1998.440213.x. [DOI] [PubMed] [Google Scholar]
  • 3.Fugh-Berman A., Epstein S. Tamoxifen: disease prevention or disease substitution? Lancet. 1992;340:1143–1145. doi: 10.1016/0140-6736(92)93161-f. [DOI] [PubMed] [Google Scholar]
  • 4.Sporn M.B. Quimioprevención del cáncer. Lancet (ed. esp.) 1994;24:229–231. [Google Scholar]
  • 5.Morgan J.W., Gladson J.E., Rai K.S. Position Paper of the American Council on Science and Health on risk factors for breast cancer: established, speculated and unsupported. Breast J. 1998;4:177–197. [Google Scholar]
  • 6.Etkind P.R., Sparano J.A. Prevention. In: Roses D.F., editor. Breast cancer (1.a ed.) Churchill Livingstone; Filadelfia: 1999. pp. 55–67. [Google Scholar]
  • 7.Cameselle J.F., Puente J.L. Exploración clínica de la mama y atención primaria. Rev Senología Patol Mam. 1999;12:57–58. [Google Scholar]
  • 8.Parker S.L., Davis K.J., Wingo P.A., Ries L.A.G., Heath C.W. Cancer statistics by race and ethnicity. CA Cancer J Clin. 1998;48:31–48. doi: 10.3322/canjclin.48.1.31. [DOI] [PubMed] [Google Scholar]
  • 9.Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J Clin. 1998;48:6–29. doi: 10.3322/canjclin.48.1.6. [DOI] [PubMed] [Google Scholar]
  • 10.Cameselle J.F. Epidemiología y factores de riesgo del cáncer de mama en el sur de Galicia (tesis doctoral). Facultad de Medicina. Universidad de Santiago de Compostela. 1988 [Google Scholar]
  • 11.World Health Orgatization . OMS; Ginebra: 1987. World Health Statictics annual. [Google Scholar]
  • 12.Kelsey J.L., Horn-Ross P.L. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev. 1993;15:7–16. doi: 10.1093/oxfordjournals.epirev.a036118. [DOI] [PubMed] [Google Scholar]
  • 13.Parkin D.M., Whelan S.L., Ferlay J., Raymond L., Young J. IARC Scientific publications n.° 143; Lyon: 1997. Cancer incidence in five continents. Vol VII. [Google Scholar]
  • 14.Garfinkel L., Boring C.C., Heath C.W. Changing trends: an overview of breast cancer incidence and mortality. Cancer. 1994;74:222–227. doi: 10.1002/cncr.2820741304. [DOI] [PubMed] [Google Scholar]
  • 15.Ruíz M., Viciana F. Tendencia y distribución geográfica de la mortalidad por cáncer de mama en Andalucía (1976-1995) Aten Primaria. 1997;20:299–304. [PubMed] [Google Scholar]
  • 16.Senra A., Palmeiro R., Herrero I., Millán J. Evolution de la mortalite par cancer du sein en Espagne. Bull Cancer. 1987;74:427–431. [PubMed] [Google Scholar]
  • 17.Rastam J., Janzon L., Olsson H. Rising incidence of breast among young women in Sweden. Br J Cancer. 1990;61:120–122. doi: 10.1038/bjc.1990.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ewertz M., Carstensen B. Trends in breast cancer incidence and mortality in Denmark 1943-1982. Int J Cancer. 1988;15:46–51. doi: 10.1002/ijc.2910410110. [DOI] [PubMed] [Google Scholar]
  • 19.White E., Daling J.R., Norsted T.L., Chu J. Rising incidence of breast cancer among young women in Washington State. J Natl Cancer Inst. 1987;79:239–243. [PubMed] [Google Scholar]
  • 20.Ries L.A.G., Kosary C.L., Hankey B.F., Miller B.A., Edwards B.K., editors. SEER. Cancer Statistics Review1973-1995. National Cancer Institute; Bethesda: 1998. [Google Scholar]
  • 21.Navarro C., Pérez D., Tortosa J., Sánchez G. Incidencia del cáncer en Murcia en 1982. Murcia: Consejería de Sanidad, Consumo y Servicios Sociales de la C.A. de Murcia. Monografía I. 1985 [Google Scholar]
  • 22.Abad J., Arrazola A., Ascunce N. Gobierno de Navarra; Pamplona: 1987. Cáncer en Navarra. Registro de tumores 1973-82. [Google Scholar]
  • 23.Ruiz J.M., Sanz J.M., Alfaro J., García-Pérez M.A., Hörndler O. Cáncer de mama. Incidencia y mortalidad en la provincia de Soria. Patología. 1991;24:99–104. [Google Scholar]
  • 24.Borrás J., Galcerán J., Anglada L.l. AECC; Tarragona: 1988. El cáncer en Tarragona 1980-1985 Estudio epidemiológico descriptivo. Registro de cáncer de Tarragona. Monografía II. [Google Scholar]
  • 25.Cameselle J.M., López A., Cameselle J.F. Exploración clínica de la mama (cinta de vídeo) Vigo. 1991 [Google Scholar]
  • 26.Sondik E.J. Breast cancer trends: incidence, mortality and survival. Cancer. 1994;74:995–999. doi: 10.1002/1097-0142(19940801)74:3+<995::aid-cncr2820741504>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  • 27.Senra A., Palmeiro R. Fisterra; Vigo: 1993. El cáncer y su prevención (1.a ed.) [Google Scholar]
  • 28.Senra A. Galicia Editorial; La Coruña: 1993. La prevención primaria del cáncer. En: Academia Galega de Ciencias, editores. El cáncer, prevención y futuro (1.a ed.) pp. 34–66. [Google Scholar]
  • 29.Ascunce N., Del Moral A. Programa de detección precoz de cáncer de mama en Navarra. Rev Senología y Patol Mam. 1990;3:96–103. [Google Scholar]
  • 30.Prats M., Marqués A., Estapé J., Ascunce N., Herranz C., Subías A. Directrices para la puesta en marcha y desarrollo de las campañas de detección precoz del cáncer de mama en España. Rev Senología y Patol Mam. 1990;3:110–113. [Google Scholar]
  • 31.Brinton L.A. Ways that women may possibly reduce their risk of breast cancer. J Natl Cancer Inst. 1994;86:1371–1372. doi: 10.1093/jnci/86.18.1371. [DOI] [PubMed] [Google Scholar]
  • 32.Love R.R. Prevention of breast cancer in premenopausal women. J Natl Cancer Inst Monogr. 1994;16:61–65. [PubMed] [Google Scholar]
  • 33.Butrum R.R., Clifford C.K., Lanza E. NCI dietary guidlines: rationales. American J Clin Nutr. 1998;48(Supl):888–895. doi: 10.1093/ajcn/48.3.888. [DOI] [PubMed] [Google Scholar]
  • 34.Fisher B., Constantino J.P., Redmond C.K., Poisson R., Bowman D., Coutuse J. Ar Randomized clinical trial evaluating tamoxifen in the treatment of patients with node.negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 1989;320:479–484. doi: 10.1056/NEJM198902233200802. [DOI] [PubMed] [Google Scholar]
  • 35.Breast Cancer Trials Comittee, Scottish Trials Office Adjuvant tamoxifen in the management of operable breast cancer: the Sottish trial. Lancet. 1987;2:171–175. [PubMed] [Google Scholar]
  • 36.Fornander T., Rutqvist L.E., Cedervnark B., Glas O., Mattsson A., Silverward C. Adjuvant tamoxifen in early breast cancer: ocurrence of new primary. Lancet. 1989;1:117–120. doi: 10.1016/s0140-6736(89)91141-0. [DOI] [PubMed] [Google Scholar]
  • 37.Early Breast Cancer Trialists’ Collaborative Group Systemic treatment of early breast cancer by hormonal, cytotoxic, or imnune therapy. 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 comen. Lancet. 1992;339:1–15. 71-85. [PubMed] [Google Scholar]
  • 38.Fisher B., Constantino J.P., Wickerham D.L., Redmon C.K., Kavanah M., Cronin W.M. Tamoxifen for the prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371–1385. doi: 10.1093/jnci/90.18.1371. [DOI] [PubMed] [Google Scholar]
  • 39.Buzdar A., Hortobagyi G.N., Frye D., Ho D., Booser D.J., Valero V. Bioequivalence of 20 mg once-daily tamoxifen relative to 10 mg twice-daily tamoxifen regimens for breast cancer. J Clin Oncol. 1994;13:50–54. doi: 10.1200/JCO.1994.12.1.50. [DOI] [PubMed] [Google Scholar]
  • 40.UICC . International Union Against Cancer. In: Day E.N., Miller A.B., editors. Screening for breast cancer. Hans Huber Publisher; Toronto: 1988. [Google Scholar]
  • 41.Simmon R.M., Osborne M.P. Prophylactic mastectomy. Breast J. 1997;3:372–379. [Google Scholar]
  • 42.Snyderman R.K. Prophylactic mastectomy: pros and cons. Cancer. 1984;53:803–808. doi: 10.1002/1097-0142(19840201)53:3+<803::aid-cncr2820531332>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  • 43.Pérez F.J., Ribeiro M., Martínez L., Ferrón M., Gaspar D., Ferrer A. Mastectomía subcutánea: revisión de nuestra experiencia en 52 casos. En: Libro de resúmenes, XVIII Congreso Nacional de la Sociedad Española de Senología y Patología Mamaria. Marbella. 1999:c-22. [Google Scholar]
  • 44.Ziegler L.D., Droll S.S. Primary breast cancer after prophylactic mastectomy. Am J Clin Oncol. 1991;14:451–454. doi: 10.1097/00000421-199110000-00018. [DOI] [PubMed] [Google Scholar]
  • 45.Pennisis V.R., Capozzi A. Subcutaneous mastectomy data: a final statistical analysis of 1500 patients. Aesthetic Plast Surg. 1989;13:15–21. doi: 10.1007/BF01570320. [DOI] [PubMed] [Google Scholar]
  • 46.Hartmann L.C., Schaid D.J., Woods J.E., Crotty T.P., Myers J.L., Arnold P.G. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340:77–84. doi: 10.1056/NEJM199901143400201. [DOI] [PubMed] [Google Scholar]
  • 47.Izquierdo M. Terapia génica y molecular en la cura del cáncer. In: Izquierdo M., editor. Biología molecular del cáncer. Síntesis; Madrid: 1995. pp. 209–227. [Google Scholar]
  • 48.Ramón y Cajal S. Carcinogénesis humana. Rev Cancer. 1999;13:116–128. [Google Scholar]
  • 49.Fabian C.J., Kimler B.F. Chemoprevention of breast cancer. Breast J. 1997;3:220–226. [Google Scholar]
  • 50.Cummings S.R., Eckert S., Krueger K.A., Grady D., Powles T.J., Cauley J.A. The effect of raloxifene on risk of brest cancer in postmenopausal women. JAMA. 1999;281:2189–2197. doi: 10.1001/jama.281.23.2189. [DOI] [PubMed] [Google Scholar]
  • 51.Fabian C. Who should receive which selective estrogen receptor modulater for prevention of breast cancer? Breast J. 1999;5:211–214. [PubMed] [Google Scholar]
  • 52.DePalo G., Camerini T., Marubini E., Costa M., Formelli F., Vecchio M Del. Chemoprevention trial of contralateral breast cancer with fenretidine. Rationales, design, methodology, organization, data management, statistics and accrual. Tumori. 1997;83:884–894. doi: 10.1177/030089169708300603. [DOI] [PubMed] [Google Scholar]
  • 53.Crowell P.L., Kennan W.S., Haag J.D. Chemoprevention of mammary carcinogenesis by hydroxylated derivatives of d-limonene. Carcinogenesis. 1992;13:1261–1264. doi: 10.1093/carcin/13.7.1261. [DOI] [PubMed] [Google Scholar]
  • 54.Torner J., Cuzick J. Prevención farmacológica del cáncer de mama. Revisión del tema. Rev Senología Patol Mam. 1995;8:33–42. [Google Scholar]
  • 55.Gómez C., Cortés H. Saned; Madrid: 1999. Quimioprevención en cáncer de mama. En: Cáncer de mama. Libro del año 1999; pp. 143–152. [Google Scholar]
  • 56.Pousa L. Facultad de Medicina, Universidad de Cádiz; Cádiz: 1998. Estudio desde diversas perspectivas del selenio en el cáncer de mama (tesis doctoral) [Google Scholar]
  • 57.Pousa L., Cortizo M.E., Cameselle J.F., Millos J., Bosco J.J., Senra A. Selenio y carcinogénesis mamaria. Rev Senología Patol Mama 1999. 2000;13:93–98. [Google Scholar]
  • 58.Cameselle J.F., Pousa L., Cortizo M.E., Campo M.C., Millos J., Lerma E. Estudio de la actividad proliferativa y grado de diferenciación del cáncer de mama en relación con los niveles de selenio tisular. Resultados preliminares. En: Libro de resúmenes, XVIII Congreso Nacional de la Sociedad Española de Senología y Patología Mamaria, Marbella. 1999:c-70. [Google Scholar]
  • 59.Powles T., Eeles R., Ashkey S., Earton D., Chang J., Dowett M. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet. 1998;352:98–101. doi: 10.1016/S0140-6736(98)85012-5. [DOI] [PubMed] [Google Scholar]
  • 60.Veronesi V., Maisonneure P., Costa A., Sacchini V., Maltoni C., Robertson C. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Lancet. 1998;352:93–97. doi: 10.1016/s0140-6736(98)85011-3. [DOI] [PubMed] [Google Scholar]
  • 61.Jordan V.C., Glusman J.E., Eckert S., Lippman M., Powles T., Costa A. Proccedings of the 34th Annual Meeting of the American Society Oncology. 1998;466 [Google Scholar]
  • 62.Messina M.J., Pensky V., Setchell K.A. Soy intake and cancer risk: a review of the in-vitro and in-vivo data. Nutr Cancer. 1994;21:113–131. doi: 10.1080/01635589409514310. [DOI] [PubMed] [Google Scholar]
  • 63.Rose D.P., Boyer A.P., Wynder E.L. International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon per capita food comsuption. Cancer. 1986;58:2363–2371. doi: 10.1002/1097-0142(19861201)58:11<2363::aid-cncr2820581102>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  • 64.McCormick D.L., Johnson W.D., Rao K.V.N., Lubet R.A., Kelloff G.J. Chemoprevention of rat mammary carcinogenesis: exceptional actvity of dictary dehydroepiandrosterone (DHEA) J Cell Biochem. 1993;17(G Supl):253–254. [Google Scholar]
  • 65.Page D.L., Dupont W.D. Anatomic markers of human premalignancy and risk of breast cancer. Cancer. 1990;66:1326–1335. doi: 10.1002/1097-0142(19900915)66:14+<1326::aid-cncr2820661405>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  • 66.Tavassoli F.A., Man Y. Morphofunctional features of intraductal hyperplasia, atypical intraductal hyperplasia, and various grades of intraductal carcinoma. Breast J. 1995;1:155–162. [Google Scholar]
  • 67.Lynch H.T., Marcus J.N., Watson P., Lynch J. Ed. Médica Panamerica; Montevideo: 1993. Cáncer de mama familiar, síndromes familiares de cáncer y predisposición al cáncer de mama. En: Bland/Copeland III. La mama. Manejo multidisciplinario de las enfermedades benignas y malignas. [Google Scholar]
  • 68.López-Touza A. Universidad de Cádiz; Cádiz: 1999. Herencia y cáncer de mama. Tesis doctoral. [Google Scholar]
  • 69.Eddy D.M. Secondary prevention of cancer: an overview. Bull WHO. 1986;64:421–429. [PMC free article] [PubMed] [Google Scholar]
  • 70.Tabár L., Duffy S.W., Vita K.B., Chen H.H., Prevost T.C. The natural history of breast carcinoma.We have we learned from screening? Cancer. 1999;86:449–462. [PubMed] [Google Scholar]
  • 71.Wilson JMG . Some principles of early diagnosis and detection. In: Teeling-Smith G., editor. Surveillance and early diagnosis in general practice. Office of Health Economics; Londres: 1996. pp. 84–97. [Google Scholar]
  • 72.Shapiro S. Then to fourteen years effects of breast cancer screening on mortality. J Natl Cancer Just. 1982;69:349. [PubMed] [Google Scholar]
  • 73.Guillén V., Llombart A. Saned; Madrid: 1999. Screening del cáncer de mama. Avances y controversias. En: Cáncer de mama. Libro del año 1999; pp. 113–128. [Google Scholar]
  • 74.Rodes N.D., Blackwell C.W., Farrell C. Selección. In: Donegan W.L., Spratt J.S., editors. Cáncer de mama (2.a ed.) Buenos; Aires: 1982. pp. 75–84. [Google Scholar]
  • 75.Eddy D.M. Screening for breast cancer. Ann Inter Med. 1989;111:389–399. doi: 10.7326/0003-4819-111-5-389. [DOI] [PubMed] [Google Scholar]
  • 76.Kopans D.B. Marbán Libros; Madrid: 1999. La mama en imagen (2.a ed.) [Google Scholar]
  • 77.Kopans D.B. Mammography screening for women over 65. J Gerontol. 1992;47:59–62. [PubMed] [Google Scholar]
  • 78.Stomper P.C., D’Souza D.J., DiNitto P.A., Arredondo M.A. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. Am J Roentgenol. 1996;167:1261–1265. doi: 10.2214/ajr.167.5.8911192. [DOI] [PubMed] [Google Scholar]
  • 79.Mittra I. In screening for breast cancer, clinical examination is as effective as mammography. BMJ. 1997;315:1234–1235. [PMC free article] [PubMed] [Google Scholar]
  • 80.Schapira D.V., Levine R.B. Detección de cáncer mamario, apego a las indicaciones y valoración de las lesiones. Clin Med Nort Am. 1996;1:15–25. [Google Scholar]
  • 81.Kopans D.B. The breast cancer screening controversy: lessons to be learned. J Surg Oncology. 1998;67:143–150. doi: 10.1002/(sici)1096-9098(199803)67:3<143::aid-jso1>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  • 82.Salvador R. Las campañas de despistaje de cáncer de mama. Rev Senología Patol Mam. 1989;2:193–196. [Google Scholar]
  • 83.Torner J., Fernández I., Granell J., Fraile E., Cortés J., Ruiz A. Screening generalizado versus screening selectivo. Rev Senología Patol Mam. 1996;10:31–43. [Google Scholar]
  • 84.Elwood J.M., Cox B., Richardson A.K. The effectiveness of breast cancer screening by mammography. Curr Clin Trials doc. 1993:32. doc. n. °. [PubMed] [Google Scholar]
  • 85.Krelkowske K., Grady D., Rubin S.L., Sandrock C., Emster V.L. Efficacy of screening mamography. A meta-analysis. JAMA. 1995;273:149–154. [PubMed] [Google Scholar]
  • 86.Barton M.B., Harris R., Fletcher S.W. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA. 1999;282:1270–1280. doi: 10.1001/jama.282.13.1270. [DOI] [PubMed] [Google Scholar]
  • 87.American Cancer Society . American Cancer Society; Atlanta: 1992. Summary of American Cancer Society recommendations for the early detection of cancer in asymptomatic people. [Google Scholar]
  • 88.American Academy of Family Physicans . American Academy of Family Physicans; Kansas City: 1993. Age charts for periodic health examination. [Google Scholar]
  • 89.American College of Obstetricians and Gynecologists . American College of Obstetricians and Gynecologists; Washington, DC: 1993. The obstetrician-gynecologist and primary-preventive health care. [Google Scholar]
  • 90.The periodic health examination: 2. 1987 update Canadian Task Force on the Periodic Health Examination. Can Med Assoc J. 1988;138:620–621. [PMC free article] [PubMed] [Google Scholar]
  • 91.Neoplastic diseases . Williams & Wilkins; Baltimore: 1989. En: U.S. Preventive Services Task Force. Guide to clynical preventive services. chaps. 6-9, 11-3 y 15. [Google Scholar]
  • 92.Womeodu R.J., Bailey J.E. Barreras para la detección de cáncer. Clin Med Nort Am. 1996;1:11–128. [Google Scholar]
  • 93.Matorras R., Tacuri C., Rodríguez M.L., Moriche A., Gutiérrez G., Lobo P. Análisis del conocimiento respecto al cáncer de mama en la población femenina. Rev Senología Pato Mam. 1992;5:29–34. [Google Scholar]
  • 94.Bernà J.D., Campos M., Martínez R., Gómez S. Modelo de selección de mujeres de alto riesgo de cáncer de mama. Rev Senología Pato Mam. 1990;3:187–191. [Google Scholar]
  • 95.Ciurana R., Calvet S., Espel C., Mendive J.M., Cos X., Pareja C. Alternativas al cribado poblacional de cáncer de mama ¿Es útil la detección oportunística? Aten Primaria. 1999;23:68–72. [PubMed] [Google Scholar]
  • 96.Fernández-Hidalgo J.M., Olmo T., López-Muñiz C. Interacción de atención primaria, especializada y paciente en un programa de detección precoz del cáncer de mama. Aten Primaria. 1998;22:425–433. [PubMed] [Google Scholar]
  • 97.Huguley C.M., Brown R.L. The value of breast self-examination. Cancer. 1981;47:989–995. doi: 10.1002/1097-0142(19810301)47:5<989::aid-cncr2820470530>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  • 98.Fletcher S.W., O'Malley M.S., Earp J., Morgan T.M., Lin S., Degnan D. How best to teach women breast self-examination. A randomized controlled trial. Ann Int Med. 1990;112:772–779. doi: 10.7326/0003-4819-112-10-772. [DOI] [PubMed] [Google Scholar]
  • 99.Taylor S.E., Luchtman R.R., Woo J.V., Bluming A.Z., Dosik G.M., Leibowitz R.L. Breast self-examination among diagnosed breast cancer patients. Cancer. 1984;54:2528–2532. doi: 10.1002/1097-0142(19841201)54:11<2528::aid-cncr2820541136>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  • 100.Cameselle J.M., López A., Cameselle J.F. Autoexamen mamario (cinta de vídeo) Vigo. 1991 [Google Scholar]
  • 101.Bernà J.D., Campos M., Martínez Gómez S. Práctica y enseñanza del autoexamen mamario. Rev Senología Pato Mam. 1990;3:244–247. [Google Scholar]
  • 102.Semiglazov V.F., Moiseenko V.M., Manikhans A.G., Protsenko S.A., Kharikova R.S., Popora R.T. Interim results of a prospective randomized study of selfexamination for early detection of breast cancer (Rusia/St.Petersburg/WHO) Vopr Onkol. 1999;45:265–271. [PubMed] [Google Scholar]
  • 103.Senra A. Principios de oncología clínica. Rev San Hig Pub. 1970;44:995–998. [PubMed] [Google Scholar]
  • 104.Alonso-Doval M.E. C. Hospitalario Xeral-Cíes; Vigo: 1998. Protocolo de enfermería en el diagnóstico y seguimiento de enfermas con cáncer de mama. [Google Scholar]
  • 105.Flórez J.A. Edika Med; Barcelona: 1994. La mujer ante el cáncer de mama: aspectos psicológicos. [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES